A double-blind, randomized, placebo-controlled evaluation of short-term treatment with oral itraconazole in patients with tinea versicolor

Journal of the American Academy of Dermatology

Volumn 34, Issue 5 I, 1996, Pages 785-787

  Hickman, Janet G ^a,b  

^a Education and Research Foundation   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ITRACONAZOLE; PLACEBO; POTASSIUM HYDROXIDE;

ADOLESCENT; ADULT; ARTICLE; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; ERYTHEMA; GASTROINTESTINAL SYMPTOM; HUMAN; PRIORITY JOURNAL; PRURITUS; RANDOMIZED CONTROLLED TRIAL; TINEA VERSICOLOR;

EID: 0030004898     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0190-9622(96)90014-6     Document Type: Article

References (5)

1. Hay RJ, Midgley G. Short course ketoconazole therapy in pityriasis versicolor. Clin Exp Dermatol 1984;9:571-3.
2. Delescluse J. Itraconazole in tinea versicolor: a review. J AM ACAD DERMATOL 1990;23:551-4.
3. Faergemann J, Jarv L. Tinea versicolor: treatment and prophylaxis with ketoconazole. Cutis 1982;30:542-5.
4. Jones HE. Ketoconazole today: a review of clinical experience. Manchester, UK: Adis Press, 1987.
5. Faergemann J. Treatment of pityriasis versicolor with itraconazole: a double-blind placebo-controlled study. Mycoses 1988;31:377-9.